SUNDAY, APRIL 15
1:00 p.m. to 2:30 p.m.
Breast Cancer Prevention
Moderator: D. Lawrence Wickerham, University of Pittsburgh, Pittsburgh, PA
- James N. Ingle, Mayo Clinic College of Medicine, Rochester, MN
- Additional speakers to be announced
Can We Target Suppressors, Particularly p53, in Cancer Therapy?
Moderator: Gerard I. Evan, UCSF Comprehensive Cancer Center and Cancer Research Institute, San Francisco, CA
- Michael A. Dyer, St. Jude Children’s Research Hospital, Memphis, TN
- Additional speakers to be announced
Mechanisms of Malignant Progression
Moderator: Robert A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, MA
- Norman E. Sharpless, University of North Carolina, Chapel Hill, NC
- Robert A. Weinberg, Whitehead Institute for Biomedical Research, Cambridge, MA
- Peter J. Houghton, St. Jude Children’s Research Hospital, Memphis, TN
Opportunistic Screening for Prostate Cancer: The Up and Down Sides of PSA Testing
Moderator: Fritz H. Schröder, Erasmus University, Rotterdam, The Netherlands
- Peter T. Scardino, Memorial Sloan-Kettering Cancer Center, New York, NY
- Additional speaker to be announced
SUNDAY, APRIL 15
2:00 p.m. to 3:15 p.m.
Science Policy and Legislative Affairs: Meet Members of the President’s Cancer Panel and Discuss the National Policy Agenda
Chairperson: William G. Nelson, V, Johns Hopkins School of Medicine, Baltimore, MD
Panelists
- LaSalle D. Leffall, Jr., Howard University, Washington, DC
- Additional panelists to be announced
MONDAY, APRIL 16
10:00 a.m. to 12:00 p.m.
Genetic Variability and Ethnicity in Cancer Treatment Outcome: Challenges and Opportunities
Presented by AACR-Minorities in Cancer Research
Co-Chairpersons: Francis Ali-Osman, Duke Comprehensive Cancer Center, Durham, NC, and Judith S. Kaur, Mayo Clinic College of Medicine, Rochester, MN
MONDAY, APRIL 16
12:30 p.m. to 2:00 p.m.
Controversies in Lung Cancer Screening
Moderator: John D. Minna, UT Southwestern Medical Center, Dallas, TX
- Claudia Henschke, Weill Medical College of Cornell University, New York, NY
- Denise R. Aberle, David Geffen School of Medicine at UCLA, Los Angeles, CA
- David P. Carbone, Vanderbilt-Ingram Cancer Center, Nashville, TN
- Stephen Lam, University of British Columbia, Vancouver, BC, Canada
Use of Antiangiogenesis Therapy in Pediatric Cancer
Moderator: Lee J. Helman, National Cancer Institute, Bethesda, MD
- Sylvain Baruchel, Hospital for Sick Children, Toronto, ON, Canada
- Chand G. Khanna, National Cancer Institute, Rockville, MD
Vaccines for Cancer Treatment: Fantasy or Reality?
Moderator: Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
- James Chung-Yin Yang, National Cancer Institute, Bethesda, MD
- Craig L. Slingluff, University of Virginia Health Science Center, Charlottesville, VA
MONDAY, APRIL 16
4:45 p.m. to 6:15 p.m.
Identifying, Preventing, and Ameliorating Late Effects in Cancer Survivors
Moderator: Lisa Diller, Dana-Farber Cancer Institute, Boston, MA
- Patricia A. Ganz, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA
- Eva Grunfeld, Nova Scotia Cancer Center, Halifax, NS, Canada
- Carol M. Moinpour, Fred Hutchinson Cancer Research Center, Seattle, WA
TUESDAY, APRIL 17
8:00 a.m. to 9:30 a.m.
Cancer Consortia: Opportunities and Challenges
Moderator: Paolo Boffetta, International Agency for Research on Cancer, Lyon, France
- David J. Hunter, Harvard University, Boston, MA
- Daniela Seminara, National Cancer Institute, Bethesda, MD
Exploring the Role of Hedgehog in Cancer
Moderator: David J. Robbins, Dartmouth Medical School, Hanover, NH
- Tom Curran, Children’s Hospital of Philadelphia, Philadelphia, PA
- Ariel Ruiz Altaba, University of Geneva Medical School, Geneva, Switzerland
Genetic Testing for Cancer Predisposition and Pharmacogenetics
Moderator: Sapna Syngal, Brigham and Women’s Hospital, Boston, MA
- Albert de la Chapelle, Ohio State University Comprehensive Cancer Center, Columbus, OH
- David A. Flockhart, Indiana University Cancer Center, Indianapolis, IN
Why Are Studies of Diet and Cancer Inconsistent?
Moderator: John D. Potter, Fred Hutchinson Cancer Research Center, Seattle, WA
- Alan R. Kristal, Fred Hutchinson Cancer Research Center, Seattle, WA
- Walter C. Willett, Harvard School of Public Health, Boston, MA
TUESDAY, APRIL 17
12:15 p.m. to 1:45 p.m.
Cancer Predisposition Genes in Breast Cancer
Moderator: Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA
Cancer Stem Cells and Their Relevance to Therapy
Moderator: David T. Scadden, Massachusetts General Hospital, Boston, MA
- Ruggero DeMaria, Fondazione IOM, Viagrande, Italy
- Craig T. Jordan, University of Rochester School of Medicine, Rochester, NY
Natural Products: Mother Nature’s Gifts to Oncology!
Moderator: David Newman, National Cancer Institute, Frederick, MD
- William Gerwick, Scripps Institution of Oceanography, La Jolla, CA
- Paul Jensen, Scripps Institution of Oceanography, La Jolla, CA
- Craig M. Crews, Yale University, New Haven, CT
The Challenges of Standardization of Molecular Profile Data
Moderator: John Quackenbush, Dana-Farber Cancer Institute, Boston, MA
- Gilbert S. Omenn, University of Michigan, Ann Arbor, MI
- Catherine A. Ball, Stanford University, Stanford, CA
WEDNESDAY, APRIL 18
8:30 a.m. to 10:00 a.m.
Kinase Inhibitors Without Cardiac Toxicity: Is a “Bullseye” Possible?
Moderator: Richard M. Steingart, Memorial Sloan-Kettering Cancer Center, New York, NY
- Peter Carmeliet, University of Leuven, Leuven, Belgium
- Michael D. Schneider, Baylor College of Medicine, Houston, TX
Small Molecules versus Antibodies in Her2 Amplified Breast Cancer
Moderator: Larry Norton, Memorial Sloan-Kettering Cancer Center, New York, NY
- Neil L. Spector, Duke University Medical Center, Durham, NC
- José Baselga, Vall d’Hebron University Hospital, Barcelona, Spain
The Role of Common SNPs in Cancer Etiology: Are Exposures Important?
Moderator: Thomas A. Sellers, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
- Genome scans to identify cancer susceptibility loci: Genes first, environment later?, Paul Pharoah, University of Cambridge, Cambridge, United Kingdom
- Genome scans identify cancer susceptibility loci: Genes and environment should be considered together?, John D. Potter, Fred Hutchinson Cancer Research Center, Seattle, WA